Company · CIK 0001131343 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
ALTERITY THERAPEUTICS LTD · ATHE
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 31, 2026 PForm 4 → | Sep 8, 7:01 pm EDT | Peter Ashley MarksDirector | 47,620 | $0.50 | $23,810 | 191,340 | +33.1% | late |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 31, 2026 PForm 4 → | Sep 8, 7:01 pm EDT | Peter Ashley MarksDirector | 47,620 | $0.50 | $23,810 | 0 | — | late |
| Aug 31, 2026 PForm 4 → | Sep 8, 6:52 pm EDT | David Allen StamlerChief Executive Officer, Director | 47,620 | $0.50 | $23,810 | 0 | — | late |